New registry aims to transform care for moms with gestational diabetes
NCT ID NCT07271407
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study enrolls 2000 women who had gestational diabetes into a registry to improve their long-term health follow-up. Participants receive reminders for regular check-ups on blood sugar, blood pressure, and other health markers over 3 years. A subgroup may also join a lifestyle program to lower diabetes risk. The goal is to learn how to better monitor and treat these women to prevent future health problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better follow-up care programs and personalized treatments for women after gestational diabetes, potentially reducing their future risk of type 2 diabetes.
- What could go wrong
- This is an observational registry study, not a treatment trial. It may not directly change outcomes, and results depend on participant adherence to follow-up.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Mar 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects with GDM will be identified through the diabetes and endocrine centre, antenatal GDM clinics and also antenatal and postnatal wards.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Women diagnosed with gestational diabetes according to the IADPSG/WHO criteria, or other locally applicable criteria, during the index pregnancy 2. Age 18-50 3. Singleton pregnancy 4. Willingness, ability and commitment to comply with study procedures 5. In the opinion of the investigator, absence of any physical limitations, addictive diseases, or underlying medical conditions (including mental health) that may preclude the patient from being a suitable study candidate. 6. Normally residing in Hong Kong 7. Able to communicate in Chinese 8. Written informed consent to participate in the study provided by the patient. 9. Willing to return for postnatal glycemic assessment and follow-up 10. Able to provide informed consent Exclusion Criteria: 1. Known current diabetes 2. Current or previous use of glucose-lowering or weight loss drugs at screening 3. Concurrent participation in other weight loss or lifestyle intervention programmes 4. Any active acute or chronic disease or condition that, in the opinion of the investigator, might interfere with the performance of this study. 5. Any active acute or chronic infectious disease that, in the opinion of the investigator, would pose an excessive risk to study staff. 6. Current use or recent exposure to any medication that in the opinion of the investigator could have an influence on the patient's ability to participate in this study or on the performance of the test device. 7. Known uncontrolled thyrotoxicosis 8. Current use of steroids 9. Known current or recent alcohol or drug abuse 10. Currently participating in another investigational study protocol where the testing or results may interfere with study compliance, diagnostic results, or data collection. 11. An identified protected vulnerable patient (including but not limited to those in detention, or a prisoner).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GDM are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital
Shatin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bedside ultrasound reveal hidden stomach contents before C-Section?
- Can olive oil and nuts in early pregnancy ward off gestational diabetes?
- Does a Mother's weight change the chemistry of her breast milk?
- Which pill tames pregnancy diabetes better?
- Weekly shot after gestational diabetes may shield new mothers from metabolic syndrome
- Can a Partner's support lower diabetes risk after gestational diabetes?